Concepedia

Nicholas Dean

ND

Statistics

Publications

14

Citations

1K

H-Index

12

Active since

1996

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Northwestern University

The Ohio State University

University of Calgary

University of Alberta

Nicholas Dean is an author at Ionis Pharmaceuticals (United States) specializing in antisense rnas, life sciences, and oncology.

Publications per year

1996–2023

14

Publications

14

Protein Kinase C-ζ Mediates Angiotensin II Activation of ERK1/2 in Vascular Smooth Muscle Cells

Duan‐Fang Liao, Brett P. Monia, Nicholas Dean et al. · Journal of Biological Chemistry · 1997 · 220 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.

Nicholas Dean, Robert A. McKay, Loren Miraglia et al. · PubMed · 1996 · 177 citations

Medicine, Oncology, Pharmacology +10

The JUN Kinase/Stress-activated Protein Kinase Pathway Is Required for Epidermal Growth Factor Stimulation of Growth of Human A549 Lung Carcinoma Cells

Frédéric Bost, Robert A. McKay, Nicholas Dean et al. · Journal of Biological Chemistry · 1997 · 173 citations · Full text

Life Sciences, Cell Biology, Oncology +16

C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma.

Yong-Min Yang, Frédéric Bost, Wilfried Charbono et al. · PubMed · 2003 · 121 citations

Life Sciences, Molecular Biology, Oncology +15

Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer

Phillip J. Gray, David J. Bearss, Haiyong Han et al. · Molecular Cancer Therapeutics · 2004 · 97 citations

Medicine, Cancer Biology, Oncology +17

1–5 of 14